2
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
50
Observational
5
Expanded_access
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Neoplasms
37
Carcinoma, Non-Small-Cell Lung
34
Multiple Myeloma
32
Recurrence
29
Prostatic Neoplasms
28
Melanoma
21
Leukemia, Myeloid, Acute
21
Breast Neoplasms
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Glioblastoma
15
Pancreatic Neoplasms
14
Sarcoma
13
Neuroblastoma
13
Lymphoma
13
Glioma
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Leukemia
10
Ovarian Neoplasms
9
Lung Neoplasms
9
Colorectal Neoplasms
9
Carcinoma, Hepatocellular
9
Small Cell Lung Carcinoma
8
Lymphoma, Large B-Cell, Diffuse
8
Lambert-Eaton Myasthenic Syndrome
8
Pheochromocytoma
7
Neuroendocrine Tumors
7
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Gastrointestinal Stromal Tumors
7
Carcinoma, Renal Cell
7
Interventions
venetoclax
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Leukemia, Plasma Cell
×
Clear all
NCT03123029
2026-01-30
Expanded Access to Venetoclax
AbbVie
Available